Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001324863-26-000002

Director sold 2,000 shares at an average $539.17 ($1,078,332)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Tommy G Director 2026-03-26 Option exercise +2,000 $101.80 $203,600 10,480 D: show line 1 in the form
Thompson Tommy G Director 2026-03-26 Sale −275 $537.62 $147,845 10,205 D: show line 2 in the form
Thompson Tommy G Director 2026-03-26 Sale −1,414 $539.25 $762,493 8,791 D: show line 3 in the form
Thompson Tommy G Director 2026-03-26 Sale −311 $540.18 $167,994 8,480 D: show line 4 in the form
Open-market sales · 2,000 sh · avg $539.17 · $1,078,332

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Thompson Tommy G Director 2026-03-26 Option exercise · Stock Option −2,000 0 D: show line 5 in the form
Loading xslF345X06/primarydocument.xml…